Skip to main content

23 April 2026

Last updated: Thursday 23 April 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Genmab looks ahead to next phase of growth

Sunday 11 November 2018

Interviewee/Contributor

Jan van de Winkel

Organisation

Genmab A/S

Why industry is investing in bispecific molecules

Wednesday 15 June 2016

Interviewee/Contributor

Jan van de Winkel

Organisation

Genmab A/S

Organisations

ImmunoBiology Ltd
MedNous editorial board
CNS Pharmaceuticals Inc
Ark Therapeutics Plc
Edmond de Rothschild Partners
Cell Medica
ICON Commercialisation and Outcomes
Merck Sharp & Dohme (Europe)
Symphogen A/S
Achilles Therapeutics Ltd

Interviewees and Contributers

Moshik Cohen-Kutner and Niv Bachnoff
Kevin FitzGerald
Philip Quinlan
Sean Morgan-Jones
Glenn Crocker
Nicole Faust
Keith Blundy
Philip Vanek
Manfred Rüdiger
Nicholas Adams

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Evotec appoints COO and CCO

Thursday 23 April 2026

Immunic appoints CNS expert to board

Thursday 16 April 2026

CEPI appoints board members

Thursday 16 April 2026

New CEO at Orano Med

Thursday 16 April 2026

Aravax names two board members

Thursday 16 April 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form